Inhalation Anesthesia Market share to reach $1.6bn by 2024

Inhalation Anesthesia Market share to reach $1.6bn
by 2024: Global Market Insights Inc.
The research report “Inhalation Anesthesia Market Size By Product (Sevoflurane,
Desflurane, Isoflurane), By Application (Induction, Maintenance Anesthesia),
Industry Analysis Report, Regional Outlook (U.S., Canada, UK, Germany,
France, Spain, Italy, China, Australia), Application Potential, Price Trends,
Competitive Market Share & Forecast, 2016 – 2024”, by Inhalation Anesthesia
Market size is set to exceed USD 1.6 billion by 2024.
Rising number of geriatric population coupled with increasing number of chronic
diseases such as cancer, cardiovascular, neurological, and respiratory disorders and
introduction of advanced anesthesia will offer lucrative growth opportunities for the
inhalation anesthesia market growth.
Increasing number of emergency surgeries driving the count of hospital admissions
coupled with favorable private and public insurance will drive the inhalation
anesthesia market. Growing investment in healthcare infrastructure development in
emerging economies and increasing adoption of universal health coverage resulting
in demand among public as well as private healthcare setups will propel the
business growth.
Increasing number of surgeries performed in ambulatory surgical centers will
stimulate business growth over the forecast years. Growing adoption of inhalation
anesthesia for globally rising prevalence of cataract surgeries, enhanced access to
healthcare treatments, and rise in disposable income will fuel the industry growth.
Adverse side effects during recovery, procedure or surgery, or wearing off
anesthesia coupled with effect like intraoperative discomfort, hypotension, postlumbar-puncture
headache, and potential for neurologic and cardiac toxicity from
anesthetics may hamper the inhalation anesthesia market growth.
Sevoflurane segment accounted for the highest revenue share in 2016 and will grow
at a significant rate over the forecast period owing to growing use in both
maintenance and induction. Isoflurane segment will grow at a significant rate
pertaining to associated factors like systemic vessels expand and potentiates
activities of muscle relaxants, preferred for neurosurgery, and sustained cardiac
outputs will boost the business growth.
1 | P a g e

U.S. Inhalation Anesthesia Market, By Product, 2013 - 2024 (USD Million)
Browse key industry insights spread across 126 pages with 148 tables & 8 market
data figures & charts from the report Inhalation Anesthesia Market in detail along
with the table of contents:
https://www.gminsights.com/industry-analysis/inhalation-anesthesia-market
Maintenance accounted for highest revenue share of the application segment in
2016 and will grow at a significant rate over the forecast period owing to factors like
safety of airway as nearly all patients that are anesthetized by means of these
products are intubated. Increasing use in patients with low oxygen carrying
capacities such as the patients with respirational dysfunction or anemia will fuel the
segment growth in the coming years.
U.S. market was valued over USD 488 million in 2016 and will grow significantly over
the coming years. Rising number of plastic surgeries and substantially increasing
adoption rate of the process will drive the business growth in U.S. Furthermore,
presence of associations that aids in maintaining the standards of anesthesiology will
fuel the industry growth in the country.
Germany accounted for highest revenue share in the region, owing to increasing
chronic conditions associated with elderly population coupled with adoption rate of
inhalation anesthesia. Growing prevalence of cancers and cardiovascular disorders
accounting for approximately 66% of overall deaths in Germany will drive the
industry growth over the forecast years.
China will grow at a significant rate owing to its growing research studies in the
business and high prevalence of lung cancer occurred due to pollution. Increasing
use of sevoflurane and desflurane in general anesthesia pertaining to superiority of
awakening afterwards surgical procedure as compared to traditional inhaled
2 | P a g e

anesthetics will drive the industry growth in the country. Presence of organizations
and associations offering platform for research and findings for anesthesia and
mounting occurrence of chronic conditions will fuel the business growth in India.
Brazil is projected to grow at a substantial rate over the forecast period. Increasing
prevalence of chronic conditions coupled with high adoption of inhalation anesthesia
technique as compared to intravenous anesthesia (AVT) will stimulate business
expansion in the country.
Some of the companies operating in market are Abbott, Baxter International,
Piramal, Lunan Pharmaceutical, Hikma Pharmaceuticals and Halocarbon Products.
Introduction of novel product and growing focus on geographical expansion will
propel the industry growth. Key industry players will endeavor to reinforce their
position in this competitive market by implementing these strategies.
Segmentation of Inhalation Anesthesia Market:
Inhalation anesthesia market research report includes in-depth coverage of the
industry with estimates & forecast in terms of revenue in USD million from 2013 to
2024, for the following segments:
Inhalation anesthesia market by product
o
o
o
Sevoflurane
Desflurane
Isoflurane
Inhalation anesthesia market by application
o
o
Induction
Maintenance
The above information is provided for the following regions and countries:
• North America
o U.S.
o Canada
• Europe
o Germany
o UK
o Italy
o France
o Spain
• Asia Pacific
o China
3 | P a g e

o India
o Australia
• Latin America
o Brazil
o Mexico
• Middle East and Africa
o South Africa
o Saudi Arabia
o UAE
About Global Market Insights:
Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market
research and consulting service provider; offering syndicated and custom research
reports along with growth consulting services. Our business intelligence and industry
research reports offer clients with penetrative insights and actionable market data
specially designed and presented to aid strategic decision making. These exhaustive
reports are designed via a proprietary research methodology and are available for
key industries such as chemicals, advanced materials, technology, renewable
energy and biotechnology.
Contact Us:
Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com
Website: https://www.gminsights.com/
4 | P a g e